Selected article for: "NLR powerful factor and powerful factor"
Author: Bicheng Zhang; Xiaoyang Zhou; Chengliang Zhu; Fan Feng; Yanru Qiu; Jia Feng; Qingzhu Jia; Qibin Song; Bo Zhu; Jun Wang
Title: Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19
  • Document date: 2020_3_16
    • ID: 68193u0a_24
    Snippet: Lymphopenia, neutrophilia, and high NLR are commonly presented and associated with more severe viral infection. 3, 11, 12 Recent data indicated that the NLR was identified as a powerful predictive and prognostic factor for severe COVID-19. 5 Thus, we develop simple combined immune response phenotypes using NLR, an indicator of innate immunity, and IgG, an indicator of acquired immunity. These four immune response phenotypes could be useful to dis.....
    Document: Lymphopenia, neutrophilia, and high NLR are commonly presented and associated with more severe viral infection. 3, 11, 12 Recent data indicated that the NLR was identified as a powerful predictive and prognostic factor for severe COVID-19. 5 Thus, we develop simple combined immune response phenotypes using NLR, an indicator of innate immunity, and IgG, an indicator of acquired immunity. These four immune response phenotypes could be useful to distinguish the severe from the nonsevere cases and predict clinical outcome. We observed more severe cases occurred in NLR hi IgG hi or NLR hi IgG lo phenotypes, with only three dead cases.

    Search related documents:
    Co phrase search for related documents
    • clinical outcome and commonly present: 1, 2
    • clinical outcome and dead case: 1
    • clinical outcome and IgG lo phenotype: 1
    • clinical outcome and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical outcome and immune response phenotype: 1, 2
    • clinical outcome and innate immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical outcome and lo phenotype: 1
    • clinical outcome and NLR hi IgG lo phenotype: 1
    • clinical outcome and response phenotype: 1, 2, 3
    • clinical outcome and severe case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical outcome predict and IgG lo phenotype: 1
    • clinical outcome predict and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • clinical outcome predict and innate immunity: 1
    • clinical outcome predict and lo phenotype: 1
    • clinical outcome predict and NLR hi IgG lo phenotype: 1
    • clinical outcome predict and severe case: 1
    • commonly present and immune response: 1, 2, 3, 4, 5, 6
    • commonly present and innate immunity: 1, 2
    • commonly present and severe case: 1, 2